2024-02-01 2025-01-31 false No description of principal activity Capium Accounts Production 1.1 14580639 2024-02-01 2025-01-31 14580639 bus:AbridgedAccounts 2024-02-01 2025-01-31 14580639 bus:Micro-entities 2024-02-01 2025-01-31 14580639 bus:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 14580639 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 14580639 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 14580639 2024-02-01 2025-01-31 14580639 2025-01-31 14580639 bus:RegisteredOffice 2024-02-01 2025-01-31 14580639 core:WithinOneYear 2025-01-31 14580639 core:AfterOneYear 2025-01-31 14580639 1 2024-02-01 2025-01-31 14580639 bus:Director1 2024-02-01 2025-01-31 14580639 bus:Director1 2025-01-31 14580639 bus:Director1 2023-01-09 2024-01-31 14580639 2023-01-09 14580639 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 14580639 2023-01-09 2024-01-31 14580639 2024-01-31 14580639 core:WithinOneYear 2024-01-31 14580639 core:AfterOneYear 2024-01-31 14580639 bus:EntityAccountantsOrAuditors 2023-01-09 2024-01-31 14580639 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 14580639 bus:OrdinaryShareClass1 2025-01-31 14580639 bus:OrdinaryShareClass1 2023-01-09 2024-01-31 14580639 bus:OrdinaryShareClass1 2024-01-31 14580639 core:PlantMachinery 2024-02-01 2025-01-31 14580639 core:PlantMachinery 2025-01-31 14580639 core:PlantMachinery 2024-01-31 14580639 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 14580639 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 14580639 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 14580639 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 14580639 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 14580639 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14580639 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 14580639 core:Non-currentFinancialInstruments 2025-01-31 14580639 core:Non-currentFinancialInstruments 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14580639
England and Wales

 

 

 

AMO PHARM LTD



Micro Entity
 


Period of accounts

Start date: 01 February 2024

End date: 31 January 2025

AMO PHARM LTD
Contents Page
For the year ended 31 January 2025
  2025   2024
    £ £   £ £
Fixed assets   373      373 
Current assets 9,312      43,902   
Creditors: amount falling due within one year (1,603)     (38,762)  
Net current assets   7,709      5,140 
Total assets less current liabilities   8,082      5,513 
Net assets   8,082      5,513 
 

         
Capital and reserves   8,082      5,513 
 
NOTES TO THE ACCOUNTS

General Information
AMO PHARM LTD is a private company, limited by shares, registered in England and Wales, registration number 14580639, registration address 133 PRINCESS ROAD, Manchester, M14 4RB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Going concern basis
The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 0% Reducing Balance
2.

Tangible fixed assets

Cost or valuation Plant and Machinery   Total
  £   £
At 01 February 2024 455    455 
Additions -    - 
Disposals -    - 
At 31 January 2025 455    455 
Depreciation
At 01 February 2024 82    82 
Charge for year -    - 
On disposals -    - 
At 31 January 2025 82    82 
Net book values
Closing balance as at 31 January 2025 373    373 
Opening balance as at 01 February 2024 373    373 


3.

Staff Costs

2025   2024
 
Average number of employees during the year Number   Number
Administration 1    1 
1    1 

4.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).


For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 09 October 2025 and were signed by:


--------------------------------
Abdullah Mahamed OSMAN
Director
1